Detection of and discrimination between total and free human interleukin-4 and free soluble interleukin-4 receptor by ELISA

Journal of Immunological Methods

Volumn 217, Issue 1-2, 1998, Pages 41-50

  Jung, Thomas ^a   Bews, John P A ^b   Enssle, Karl Heinz ^c   Wagner, Katrin ^b   Neumann, Christine ^a   Heusser, Christoph H ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b NOVARTIS PHARMA AG   (Switzerland)

^c Behringwerke AG   (Germany)

Author keywords

ELISA; IL 4; sIL 4R

Indexed keywords

EPITOPE; INTERLEUKIN 4; INTERLEUKIN 4 ANTIBODY; INTERLEUKIN 4 RECEPTOR; MONOCLONAL ANTIBODY; RECEPTOR ANTIBODY;

ALPHA CHAIN; ANTIBODY AFFINITY; ANTIGEN ANTIBODY REACTION; ANTIGEN RECOGNITION; ARTICLE; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; INHIBITION KINETICS; LYMPHOCYTE CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN DOMAIN; RECEPTOR BINDING; T LYMPHOCYTE;

ANTIBODIES, MONOCLONAL; CULTURE MEDIA, CONDITIONED; DERMATITIS, ATOPIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; HUMANS; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; LYMPHOMA, T-CELL, CUTANEOUS; PROTEIN BINDING; RECEPTORS, INTERLEUKIN-4; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; SOLUBILITY;

EID: 0032144272     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(98)00084-2     Document Type: Article

References (30)

1. Andersson U., Andersson J., Lindfors A., Wagner K., Möller G., Heusser C.H. Simultaneous production of interleukin 2, interleukin 4 and interferon by activated human blood lymphocytes. Eur. J. Immunol. 20:1990;1591.
2. Bradding P., Feather I.H., Howarth P.H., Mueller R., Roberts J.A., Britten K., Bews J.P.A., Hunt X., Okayama Y., Heusser C.H., Bullock G.R., Church M.K., Holgate S.T. Interleukin 4 is localized to and released by human mast cells. J. Exp. Med. 176:1992;1381.
3. Breit S., Steinhoff M., Blaser K., Heusser C.H., Sebald W., Levin A.D., Röcken M. A strict requirement of IL-4 for IL-4 induction in antigen stimulated human memory T cells. Eur. J. Immunol. 26:1996;1860.
4. Brinkmann V., Heusser C.H. T-cell-dependent differentiation of human B-cells into IgM, IgG, IgA, IgE plasma cells: high rate of antibody production by IgE plasma cells, but limited clonal expansion of IgE production. Cell. Immunol. 152:1993;323.
5. + T cells. J. Exp. Med. 178:1993;1655.
6. Brunner T., Heusser C.H., Dahinden C.A. Human peripheral blood basophils primed by IL-3 produce IL-4 in response to IgE receptor stimulation. J. Exp. Med. 177:1993;605.
7. Enssle K., Enders B., Kurrle R., Lauffer L., Schorlemmer H.U., Dickneite G., Kanzy E.J., Seiler F.R. Biology of natural and recombinant soluble interleukin-4 receptor. Behring. Inst. Mitt. 96:1995;103.
8. Enssle K., Schulz G. Regulation of interleukin-4 activity by soluble interleukin-4 receptors. J. Clin. Lab. Anal. 9:1995;450.
9. Fernandez Botran R. Soluble cytokine receptors: their role in immunoregulation. FASEB J. 5:1991;2567.
10. Fernandez Botran R., Vitetta E.S. A soluble, high-affinity, interleukin-4-binding protein is present in the biological fluids of mice. Proc. Natl. Acad. Sci. U.S.A. 87:1990;4202.
11. Fernandez Botran R., Vitetta E.S. Evidence that natural murine soluble interleukin 4 receptors may act as transport proteins. J. Exp. Med. 174:1991;673.
12. The Soluble TNF Receptor Sepsis Study Group, Fisher C.J. Jr., Agosti J.M., Opal S.M., Lowry S.F., Balk R.A., Sadoff J.C., Abraham E., Schein R.M., Benjamin E. Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein. New Engl. J. Med. 334:1996;1697.
13. Garrone P., Djossou O., Galizzi J.P., Banchereau J. A recombinant extracellular domain of the human interleukin 4 receptor inhibits the biological effects of interleukin 4 on T and B lymphocytes. Eur. J. Immunol. 21:1991;1365.
14. Gessner A., Schroppel K., Will A., Enssle K.H., Lauffer L., Rollinghoff M. Recombinant soluble interleukin-4 (IL-4) receptor acts as an antagonist of IL-4 in murine cutaneous Leishmaniasis. Infect. Immun. 62:1994;4112.
15. Idzerda R.L., March C.J., Mosley B., Lyman S.D., Bos T.V., Gimpel S.D., Din W.S., Grabstein K.H., Widmer M.B., Park L.S., Cosman D., Beckmann M.P. Human interleukin 4 receptor confers biological responsiveness and defines a novel receptor superfamily. J. Exp. Med. 171:1990;861.
16. Jacobs C.A., Lynch D.H., Roux E.R., Miller R., Davis B., Widmer M.B., Wignall J., VandenBos T., Park L.S., Beckmann M.P. Characterization and pharmacokinetic parameters of recombinant soluble interleukin-4 receptor. Blood. 77:1991;2396.
17. Jung T., Schauer U., Heusser C., Neumann C., Rieger C. Detection of intracellular cytokines by flow cytometry. J. Immunol. Methods. 159:1993;197.
18. Jung T., Schauer U., Rieger C., Wagner K., Einsle K., Neumann C., Heusser C. Interleukin-4 and interleukin-5 are rarely co-expressed by human T cells. Eur. J. Immunol. 25:1995;2413.
19. Kilchherr, E., Heusser, C.H., 1992. In: Haeberli, A. (Ed.), Interleukin 4, Human Protein Data. VCH Verlag, Weinheim BRD.
20. Maliszewski C.R., Sato T.A., Davison B., Jacobs C.A., Finkelman F.D., Fanslow W.C. In vivo biological effects of recombinant soluble interleukin-4 receptor. Proc. Soc. Exp. Biol. Med. 206:1994;233.
21. Mosley B., Beckmann M.P., March C.J., Idzerda R.I., Gimpel S.D., VandenBos T., Friend D., Alpert A., Anderson D., Jackson J., Wignall J.M., Smith C., Gallis B., Sims J.E., Urdal D., Widmer M.B., Cosman D., Park L.S. The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms. Cell. 59:1989;335.
22. Mosmann T.R., Cofmann R.L. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:1989;145.
23. Novick D., Engelmann H., Wallach D., Rubinstein M. Soluble cytokine receptors are present in normal human urine. J. Exp. Med. 170:1989;1409.
24. Park L.S., Friend D., Sassenfeld H.M., Urdal D.L. Characterization of the human B cell stimulatory factor 1 receptor. J. Exp. Med. 166:1987;476.
25. Puccetti P., Mencacci A., Cenci E., Spaccapelo R., Mosci P., Enssle K.H., Romani L., Bistoni F. Cure of murine candidiasis by recombinant soluble interleukin-4 receptor. J. Infect. Dis. 169:1994;1325.
26. Reusch P., Arnold S., Heusser C., Wagner K., Weston B., Sebald W. Neutralizing monoclonal antibodies define two different functional sites in human interleukin-4. Eur. J. Biochem. 222:1994;491.
27. Russell S.M., Keegan A.D., Harada N., Nakamura Y., Noguchi M., Leland P., Friedmann M.C., Miyajima A., Puri R.K., Paul W.E.et al. Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor. Science. 262:1993;1880.
28. Sager N., Feldmann A., Schilling G., Kreitsch P., Neumann C. House dust mite-specific T cells in the skin of subjects with atopic dermatitis: frequency and lymphokine profile in the allergen patch test. J. Allergy Clin. Immunol. 89:1992;801.
29. Sato T.A., Widmer M.B., Finkelman F.D., Madani H., Jacobs C.A., Grabstein K.H., Maliszewski C.R. Recombinant soluble murine IL-4 receptor can inhibit or enhance IgE responses in vivo. J. Immunol. 150:1993;2717.
30. Schauer U., Schmitt M., Müller S., Enssle K., Kurrle R., Sundermann U., Bender A., Wahn U., Rieger C.H.L. Soluble interleukin-4 receptor in atopic children. Int. Arch. Allergy Immunol. 108:1995;175.